- This event has passed.
The MDS Foundation’s Outcomes for High-Risk MDS Patients Undergoing Transplant vs. Standard Non-Transplant Therapies Webinar
August 7, 2021 @ 12:00 pm - 1:00 pm
Outcomes for High-Risk MDS Patients Undergoing Transplant vs. Standard Non-Transplant Therapies
August 7, 2021
Speaker: Erica D. Warlick, MD, University of Minnesota Medical Center
This free webinar provides an overview of allogeneic hematopoietic cell transplant as a treatment for high-risk MDS. This approach will be compared with other common treatment approaches, such as hypomethylating agents and other novel agents.
To register, click here.
